Les derniers communiqués publiés par les sociétés

DIAGNOSTIC MEDICAL (EPA:DGM)

03/10/2022 17:00

2022 bi-annual results: 4.6% of EBITDA margin Including 10.3% for the DMS Imaging division - Presentation of the future strategic plan in October 2022

Voir tous les communiqués de DIAGNOSTIC MEDICAL

BLACK TUSK RESOURCES INC. (:TUSK)

03/10/2022 16:55

Black Tusk Resources Inc. Receives Permit to Drill VMS Targets on the MoGold and PG Highway Projects, Quebec

Voir tous les communiqués de Black Tusk Resources Inc.

DESO

03/10/2022 16:45

USDC Will Integrate With Decentralized Social to Bring Web3 to The Masses

Voir tous les communiqués de DeSo

RIGHTS AND ISSUES INVESTMENT TRUST PLC

03/10/2022 16:23

Rights and Issues Investment Trust PLC: Appointment of Investment Manager and Alternative Investment Fund Manager

Voir tous les communiqués de Rights and Issues Investment Trust PLC

STHREE (FRA:GB00B0KM)

03/10/2022 15:46

SThree: TVR-Total Voting Rights

Voir tous les communiqués de SThree

SEKUR PRIVATE DATA LTD. (NASDAQ:SWISF)

03/10/2022 15:40

Sekur Private Data Ltd. Increases Sales for Q3 2022 Sales Up 160% Compared to Q3 2021 - Increases Active Paid Users by 230% in Same Period

Voir tous les communiqués de Sekur Private Data Ltd.

OJSC PHOSAGRO

03/10/2022 15:30

PhosAgro PJSC: Independent Director Viktor Cherepov Elected Chairman of PhosAgro Board of Directors

Voir tous les communiqués de OJSC PhosAgro

HEALTHCARE TRIANGLE, INC.

03/10/2022 15:28

EQS-News: EF Hutton Reiterates Buy Rating On HCTI, Second Time in 2022

Voir tous les communiqués de Healthcare Triangle, Inc.

LAYERX

03/10/2022 15:20

LayerX Emerges From Stealth To Launch User-First Security Platform For All Browsers

Voir tous les communiqués de LayerX

PASITHEA THERAPEUTICS CORP.

03/10/2022 15:09

EQS-News: Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis

Voir tous les communiqués de Pasithea Therapeutics Corp.

«
1
2
3
4
5
6
7
8
9
10
»